TLR3 and Schwartz-Jampel syndrome: These findings led us to suspect that TLR3 was able to positively regulate mucocutaneous inflammation of the skin and ocular surface (22) and might contribute the mucocutaneous inflammation seen in patients with SJS/TEN with SOC (22).